Symbiosis Pharmaceutical

Activities: Manufacturing

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA...
  2. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  3. Domino’s Adem Kulauzovic appointed to the Board of OMAC Domino’s Adem Kulauzovic appointed to the Board of OMAC to help shape the future of packaging automation
  4. Manufacturing Chemist Stand Side with Almac Group We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  5. Ardena strengthens leadership team with new quality and information officers Appointments reinforce focus on quality, compliance, and digital integration across global operations

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

Related Content

Manufacturing

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
Manufacturing

Symbiosis reaches major milestone with 1,000th batch of injectable drug product

Symbiosis Pharmaceutical Services, a global contract manufacturing organisation (CMO), today announced the successful completion of its 1,000th sterile drug product batch, marking a significant milestone in its mission to accelerate access to life-changing medicines worldwide

Symbiosis honoured with prestigious King’s Award for Enterprise for International Trade

Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill finish of injectable drug products has been awarded a 2025 King’s Award for Enterprise in the International Trade category, the UK’s highest official accolade for British businesses
Manufacturing

Symbiosis completes successful MHRA audit of new sterile fill/finish facility

Symbiosis completes successful MHRA audit of new sterile fill/finish facility, expanding global manufacturing capacity
Regulatory

Quality and compliance: the foundation of trust

As the CEO of Symbiosis, a contract manufacturing organisation (CMO) licenced to manufacture sterile medicinal products, Colin MacKay understands the profound responsibility involved in ensuring that the products they manufacture meet the highest quality standards and adhere to all relevant regulatory requirements
Sustainability

Symbiosis earns recognition from EcoVadis for commitment to sustainability

Symbiosis has been awarded a Committed Badge through the EcoVadis recognition system for its efforts in carbon reduction and alignment with the Science Based Targets initiative (SBTi)
Manufacturing

Symbiosis successfully completes gene therapy focussed FDA regulatory inspection

Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has successfully completed its latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland
Subscribe now